Quest Diagnostics Aktie

Quest Diagnostics für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 904533 / ISIN: US74834L1008

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
22.07.2025 20:19:56

Quest Diagnostics Boosts Its 2025 Outlook

Quest Diagnostics (NYSE:DGX) reported its second-quarter 2025 results on July 22, achieving consolidated revenue of $2.76 billion (up 15.2% year over year), organic revenue growth of 5.2%, while adjusted EPS rose 11.5% year over year to $2.62. Management raised full-year revenue guidance to $10.8 billion to $10.92 billion and adjusted EPS to $9.63 to $9.83, citing sustained demand for advanced diagnostics, the integration of last year's LifeLabs acquisition, and scale-driven productivity gains. Investors should note updated mid-term expectations for growth drivers, operational efficiencies, and regulatory risk exposure discussed below.Reported operating income increased to $438 million and adjusted operating income was $466 million, expanding margins by 110 basis points and 30 basis points year over year, respectively, reflecting strategic automation deployments. Cash from operations surged 67.1% year to date to $858 million, aided by a one-time CARES Act tax credit and the timing of receipts and disbursements.Systematic automation rollouts underpin the company’s targeted 3% annual cost and productivity improvement forecast.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Analysen zu Quest Diagnostics Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Quest Diagnostics Inc. 151,90 7,27% Quest Diagnostics Inc.